Differential effect of ethanol intoxication on peripheral markers of cerebral injury in murine blunt traumatic brain injury

Abstract

Background: Blood-based biomarkers have proven to be a reliable measure of the severity and outcome of traumatic brain injury (TBI) in both murine models and patients. In particular, neuron-specific enolase (NSE), neurofilament light (NFL) and S100 beta (S100B) have been investigated in the clinical setting post-injury. Ethanol intoxication (EI) remains a significant comorbidity in TBI, with 30–40% of patients having a positive blood alcohol concentration post-TBI. The effect of ethanol on blood-based biomarkers for the prognosis and diagnosis of TBI remains unclear. In this study, we investigated the effect of EI on NSE, NFL and S100B and their correlation with blood–brain barrier integrity in a murine model of TBI. Methods: We used ultra-sensitive single-molecule array technology and enzyme-linked immunosorbent assay methods to measure NFL, NSE, S100B and claudin-5 concentrations in plasma 3 hours post-TBI. Results: We showed that NFL, NSE and S100B were increased at 3 hours post-TBI. Interestingly, ethanol blood concentrations showed an inverse correlation with NSE but not with NFL or S100B. Claudin-5 levels were increased post-injury but no difference was detected compared to ethanol pretreatment. The increase in claudin-5 post-TBI was correlated with NFL but not with NSE or S100B. Conclusions: Ethanol induces an effect on biomarker release in the bloodstream that is different from TBI not influenced by alcohol. This could be the basis of investigations into humans.

Keywords

Traumatic brain injury / Ethanol / Biomarkers / neurofilament light / neuron-specific enolase / S100B / Claudin-5

References

[1] Thelin E, Al Nimer F, Frostell A, Zetterberg H, Blennow K, Nyström H et al. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury. J Neurotrauma. 2019; 36: 2850-62.

[2] Agoston DV, Shutes-David A, Peskind ER. Biofluid biomarkers of traumatic brain injury. Brain Inj. 2017; 31: 1195-203.

[3] Ruslin M, Wolff J, Yusuf HY, Arifin MZ, Boffano P, Forouzanfar T. Use of neuron-specific enolase to predict mild brain injury in motorcycle crash patients with maxillofacial fractures: A pilot study. Chin J Traumatol. 2019; 22: 47-50.

[4] Meric E, Gunduz A, Turedi S, Cakir E, Yandi M. The prognostic value of neuron-specific enolase in head trauma patients. J Emerg Med. 2010; 38: 297-301.

[5] Guzel A, Er U, Tatli M, Aluclu U, Ozkan U, Duzenli Y et al. Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury. Neurosurg Rev. 2008; 31: 439-44; discussion 444-5. https://doi.org/10.1007/s10143-008-0148-2.

[6] Sun Y, Wang S, Gan S, Niu X, Yin B, Bai G et al. Serum Neuron-Specific Enolase Levels Associated with Connectivity Alterations in Anterior Default Mode Network after Mild Traumatic Brain Injury. J Neurotrauma. 2021; 38: 1495-505.

[7] Shahim P, Gren M, Liman V, Andreasson U, Norgren N, Tegner Y et al. Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Sci Rep. 2016; 6: 36791. https://doi.org/10.1038/srep36791.

[8] Guedes VA, Kenney K, Shahim P, Qu BX, Lai C, Devoto C et al. Exosomal neurofilament light: A prognostic biomarker for remote symptoms after mild traumatic brain injury? Neurology. 2020; 94: e2412-23.

[9] Soylu-Kucharz R, Sandelius Å, Sjögren M, Blennow K, Wild EJ, Zetterberg H et al. Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington’s disease R6/2 mice. Sci Rep. 2017; 7: 14114. https://doi.org/10.1038/s41598-017-14179-1.

[10] Weydt P, Oeckl P, Huss A, Müller K, Volk AE, Kuhle J et al. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis. Ann Neurol. 2016; 79: 152-8. https://doi.org/10.1002/ana.24552.

[11] Czeiter E, Amrein K, Gravesteijn BY, Lecky F, Menon DK, Mondello S et al. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity. CT findings and care path in the CENTER-TBI study. EBioMedicine. 2020; 56: 102785. https://doi.org/10.1016/j.ebiom.2020.102785.

[12] Jones CMC, Harmon C, McCann M, Gunyan H, Bazarian JJ. S100B outperforms clinical decision rules for the identification of intracranial injury on head CT scan after mild traumatic brain injury. Brain Inj. 2020; 34: 407-14.

[13] Goodman MD, Makley AT, Campion EM, Friend LA, Lentsch AB, Pritts TA. Preinjury alcohol exposure attenuates the neuroinflammatory response to traumatic brain injury. J Surg Res. 2013; 184: 1053-8.

[14] Yang Y, Zhang XJ, Zhang C, Chen R, Li L, He J et al. Loss of neuronal CD200 contributed to microglial activation after acute cerebral ischemia in mice. Neurosci Lett. 2018; 678: 48-54.

[15] Mattsson N, Andreasson U, Zetterberg H. Blennow K ; Alzheimer’s Disease Neuroimaging Initiative. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease. JAMA Neurol. 2017; 74: 557-66.

[16] Cheng WH, Stukas S, Martens KM, Namjoshi DR, Button EB, Wilkinson A et al. Age at injury and genotype modify acute inflammatory and neurofilament-light responses to mild CHIMERA traumatic brain injury in wild-type and APP/PS1 mice. Exp Neurol. 2018; 301: 26-38.

[17] Bjarkø VV, Skandsen T, Moen KG, Gulati S, Helseth E, Nilsen TIL et al. Time of Injury and Relation to Alcohol Intoxication in Moderate-to-Severe Traumatic Brain Injury: A Decade-Long Prospective Study. World Neurosurg. 2019; 122: e684-9.

[18] Zaloshnja E, Miller T, Langlois JA, Selassie AW. Prevalence of long-term disability from traumatic brain injury in the civilian population of the United States, 2005. J Head Trauma Rehabil. 2008; 23: 394-400.

[19] Lange RT, Iverson GL, Brubacher JR. Clinical utility of the protein S100B to evaluate traumatic brain injury in the presence of acute alcohol intoxication. J Head Trauma Rehabil. 2012; 27: 123-34.

[20] Brin T, Borucki K, Ambrosch A. The influence of experimental alcohol load and alcohol intoxication on S100B concentrations. Shock. 2011; 36: 356-60. https://doi.org/10.1097/SHK.0b013e31822bd07d.

[21] Calcagnile O, Holmén A, Chew M, Undén J. S100B levels are affected by older age but not by alcohol intoxication following mild traumatic brain injury. Scand J Trauma Resusc Emerg Med. 2013; 21: 52. https://doi.org/10.1186/1757-7241-21-52.

[22] Brigode W, Cohan C, Beattie G, Victorino G. Alcohol in Traumatic Brain Injury: Toxic or Therapeutic? J Surg Res. 2019; 244: 196-204.

[23] Raj R, Mikkonen ED, Siironen J, Hernesniemi J, Lappalainen J, Skrifvars MB. Alcohol and mortality after moderate to severe traumatic brain injury: a meta-analysis of observational studies. J Neurosurg. 2016; 124: 1684-92.

[24] Brennan JH, Bernard S, Cameron PA, Rosenfeld JV, Mitra B. Ethanol and isolated traumatic brain injury. J Clin Neurosci. 2015; 22: 1375-81.

[25] Raj R, Skrifvars MB, Kivisaari R, Hernesniemi J, Lappalainen J, Siironen J. Acute alcohol intoxication and long-term outcome in patients with traumatic brain injury. J Neurotrauma. 2015; 32: 95-100.

[26] Mohseni S, Bellander BM, Riddez L, Talving P, Thelin EP. Positive blood alcohol level in severe traumatic brain injury is associated with better long-term functional outcome. Brain Inj. 2016; 30: 1256-60.

[27] Shandro JR, Rivara FP, Wang J, Jurkovich GJ, Nathens AB, MacKenzie EJ. Alcohol and risk of mortality in patients with traumatic brain injury. J Trauma. 2009; 66: 1584-90.

[28] Yue JK, Ngwenya LB, Upadhyayula PS, Deng H, Winkler EA, Burke JF et al. Emergency department blood alcohol level associates with injury factors and six-month outcome after uncomplicated mild traumatic brain injury. J Clin Neurosci. 2017; 45: 293-8.

[29] Chandrasekar A, Heuvel FO, Palmer A, Linkus B, Ludolph AC, Boeckers TM et al. Acute ethanol administration results in a protective cytokine and neuroinflammatory profile in traumatic brain injury. Int Immunopharmacol. 2017; 51: 66-75.

[30] Chandrasekar A, Aksan B, Heuvel FO, Förstner P, Sinske D, Rehman R et al. Neuroprotective effect of acute ethanol intoxication in TBI is associated to the hierarchical modulation of early transcriptional responses. Exp Neurol. 2018; 302: 34-45.

[31] Chandrasekar A, Olde Heuvel F, Wepler M, Rehman R, Palmer A, Catanese A et al. The Neuroprotective Effect of Ethanol Intoxication in Traumatic Brain Injury Is Associated with the Suppression of ErbB Signaling in Parvalbumin-Positive Interneurons. J Neurotrauma. 2018; 35: 2718- 35.

[32] Olde Heuvel F, Holl S, Chandrasekar A, Li Z, Wang Y, Rehman R et al. STAT6 mediates the effect of ethanol on neuroinflammatory response in TBI. Brain Behav Immun. 2019; 81: 228-46.

[33] Teng SX, Katz PS, Maxi JK, Mayeux JP, Gilpin NW, Molina PE. Alcohol exposure after mild focal traumatic brain injury impairs neurological recovery and exacerbates localized neuroinflammation. Brain Behav Immun. 2015; 45: 145-56.

[34] Teng SX, Molina PE. Acute alcohol intoxication prolongs neuroinflammation without exacerbating neurobehavioral dysfunction following mild traumatic brain injury. J Neurotrauma. 2014; 31: 378-86.

[35] Faul M, Coronado V. Epidemiology of traumatic brain injury. Handb Clin Neurol. 2015; 127: 3-13.

[36] Peeters W, van den Brande R, Polinder S, Brazinova A, Steyerberg EW, Lingsma HF et al. Epidemiology of traumatic brain injury in Europe. Acta Neurochir (Wien). 2015; 157: 1683-96.

[37] Iaccarino C, Carretta A, Nicolosi F, Morselli C. Epidemiology of severe traumatic brain injury. J Neurosurg Sci. 2018; 62: 535-41.

[38] Flierl MA, Stahel PF, Beauchamp KM, Morgan SJ, Smith WR, Shohami E. Mouse closed head injury model induced by a weight-drop device. Nat Protoc. 2009; 4: 1328-37.

[39] Franz N, Dieteren S, Köhler K, Mörs K, Sturm R, Marzi I et al. Alcohol Binge Reduces Systemic Leukocyte Activation and Pulmonary PMN Infiltration After Blunt Chest Trauma and Hemorrhagic Shock. Inflammation. 2019; 42: 690-701.

[40] Wagner N, Franz N, Dieteren S, Perl M, Mörs K, Marzi I, et al. Acute Alcohol Binge Deteriorates Metabolic and Respiratory Compensation Capability After Blunt Chest Trauma Followed by Hemorrhagic Shock-A New Research Model. Alcohol Clin Exp Res. 2017; 41: 1559-67.

[41] Steinacker P, Semler E, Anderl-Straub S, Diehl-Schmid J, Schroeter ML, Uttner I et al. Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias. Neurology. 2017; 88: 961-9.

[42] Cash A, Theus MH. Mechanisms of Blood-Brain Barrier Dysfunction in Traumatic Brain Injury. Int J Mol Sci. 2020; 21: 3344. https://doi.org/10.3390/ijms21093344.

[43] Plog BA, Dashnaw ML, Hitomi E, Peng W, Liao Y, Lou N et al. Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. J Neurosci. 2015; 35: 518-26. https://doi.org/10.1523/JNEUROSCI.3742-14.2015.

[44] Ahmed F, Gyorgy A, Kamnaksh A, Ling G, Tong L, Parks S et al. Time-dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury. Electrophoresis. 2012; 33: 3705-11.

[45] Goetzl EJ, Elahi FM, Mustapic M, Kapogiannis D, Pryhoda M, Gilmore A et al. Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury. FASEB J. 2019; 33: 5082-8.

[46] Anthony DC, Couch Y. The systemic response to CNS injury. Exp Neurol. 2014; 258: 105-11.

[47] Moinard C, Gupta S, Besson V, Morio B, Marchand-Leroux C, Chaumeil JC et al. Evidence for impairment of hepatic energy homeostasis in head-injured rat. J Neurotrauma. 2008; 25: 124-9.

[48] Bao F, Brown A, Dekaban GA, Omana V, Weaver LC. CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury. Exp Neurol. 2011; 231: 272-83.

[49] Park DW, Park SH, Hwang SK. Serial measurement of S100B and NSE in pediatric traumatic brain injury. Childs Nerv Syst. 2019; 35: 343-8.

[50] Shahim P, Politis A, van der Merwe A, Moore B, Chou YY, Pham DL et al. Neurofilament light as a biomarker in traumatic brain injury. Neurology. 2020; 95: e610-22.

[51] Liu KL, Yu XJ, Sun TZ, Wang YC, Chen MX, Su YW,et al. Effects of seawater immersion on open traumatic brain injury in rabbit model. Brain Res. 2020; 1743: 146903.

[52] Vogt N, Herden C, Roeb E, Roderfeld M, Eschbach D, Steinfeldt T et al. Cerebral Alterations Following Experimental Multiple Trauma and Hemorrhagic Shock. Shock. 2018; 49: 164-73. https://doi.org/10.1097/SHK.0000000000000943.

[53] Li Y, Lv W, Cheng G, Wang S, Liu B, Zhao H et al. Effect of Early Normobaric Hyperoxia on Blast-Induced Traumatic Brain Injury in Rats. Neurochem Res. 2020; 45: 2723-31.

[54] Ahmed F, Plantman S, Cernak I, Agoston DV. The Temporal Pattern of Changes in Serum Biomarker Levels Reveals Complex and Dynamically Changing Pathologies after Exposure to a Single Low-Intensity Blast in Mice. Front Neurol. 2015; 6: 114. https://doi.org/10.3389/fneur.2015.00114.

[55] Isgrò MA, Bottoni P, Scatena R. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects. Adv Exp Med Biol. 2015; 867: 125-43.

[56] Pelinka LE, Hertz H, Mauritz W, Harada N, Jafarmadar M, Albrecht M et al. Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings. Shock. 2005; 24: 119-23. https://doi.org/10.1097/01.shk.0000168876.68154.43.

[57] Johnsson P. Markers of cerebral ischemia after cardiac surgery. J Cardiothorac Vasc Anesth. 1996; 10: 120-6.

[58] Winther-Larsen A, Hviid CVB, Meldgaard P, Sorensen BS, Sandfeld-Paulsen B. Neurofilament Light Chain as A Biomarker for Brain Metastases. Cancers (Basel). 2020; 12: 2852. https://doi.org/10.3390/cancers12102852.

[59] Martín-Aguilar L, Camps-Renom P, Lleixà C, Pascual-Goñi E, Díaz-Manera J, Rojas-García R et al. Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients. J Neurol Neurosurg Psychiatry. 2020;jnnp- 2020-323899.

[60] Sapin V, Gaulmin R, Aubin R, Walrand S, Coste A, Abbot M. Blood biomarkers of mild traumatic brain injury: State of art. Neurochirurgie. 2021; 67: 249-54.

[61] Ferreira-Atuesta C, Reyes S, Giovanonni G, Gnanapavan S. The Evolution of Neurofilament Light Chain in Multiple Sclerosis. Front Neurosci. 2021; 15: 642384. https://doi.org/10.3389/fnins.2021.642384.

[62] Shahim P, Tegner Y, Marklund N, Blennow K, Zetterberg H. Neurofilament light and tau as blood biomarkers for sports-related concussion. Neurology. 2018; 90: e1780-8.

[63] Disanto G, Barro C, Benkert P, Naegelin Y, Schädelin S, Giardiello A et al. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis. Ann Neurol. 2017; 81: 857-70.

[64] Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019; 90: 870-81.

[65] Haque A, Polcyn R, Matzelle D, Banik NL. New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection. Brain Sci. 2018; 8: 33. https://doi.org/10.3390/brainsci8020033.

[66] Gassenmaier M, Lenders MM, Forschner A, Leiter U, Weide B, Garbe C et al. Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors. Target Oncol. 2021; 16: 197-205.

[67] Albrecht JS, Afshar M, Stein DM, Smith GS. Association of Alcohol With Mortality After Traumatic Brain Injury. Am J Epidemiol. 2018; 187: 233-41.

[68] Ouali Alami N, Tang L, Wiesner D, Commisso B, Bayer D, Weishaupt J et al. Multiplexed chemogenetics in astrocytes and motoneurons restore blood-spinal cord barrier in ALS. Life Sci Alliance. 2020; 3: e201900571. https://doi.org/10.26508/lsa.201900571.

[69] Zhao GJ, Li D, Zhao Q, Lian J, Hu TT, Hong GL et al. PROGNOSTIC VALUE OF PLASMA TIGHT-JUNCTION PROTEINS FOR SEPSIS IN EMERGENCY DEPARTMENT: AN OBSERVATIONAL STUDY. Shock. 2016; 45: 326-32. https://doi.org/10.1097/SHK.0000000000000524.

[70] Gumber S, Nusrat A, Villinger F. Immunohistological characterization of intercellular junction proteins in rhesus macaque intestine. Exp Toxicol Pathol. 2014; 66: 437-44.

[71] Koda R, Zhao L, Yaoita E, Yoshida Y, Tsukita S, Tamura A et al. Novel expression of claudin-5 in glomerular podocytes. Cell Tissue Res. 2011; 343: 637-48.

[72] Andersson EA, Mallard C, Ek CJ. Circulating tight-junction proteins are potential biomarkers for blood-brain barrier function in a model of neonatal hypoxic/ischemic brain injury. Fluids Barriers CNS. 2021; 18: 7. https://doi.org/10.1186/s12987-021-00240-9.

[73] Jiao X, He P, Li Y, Fan Z, Si M, Xie Q et al. The Role of Circulating Tight Junction Proteins in Evaluating Blood Brain Barrier Disruption following Intracranial Hemorrhage. Dis Markers. 2015; 2015: 860120.

[74] Zhu JC, Si MY, Li YZ, Chen HZ, Fan ZC, Xie QD et al. Circulating tight junction proteins mirror blood-brain barrier integrity in leukaemia central nervous system metastasis. Hematol Oncol. 2017; 35: 365-73. https://doi.org/10.1002/hon.2289.

[75] Kazmierski R, Michalak S, Wencel-Warot A, Nowinski WL. Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients. Neurology. 2012; 79: 1677-85.

[76] Lindblad C, Nelson DW, Zeiler FA, Ercole A, Ghatan PH, von Horn H et al. Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study. J Neurotrauma. 2020; 37: 1381-91.

[77] Kerr N, Lee SW, Perez-Barcena J, Crespi C, Ibañez J, Bullock MR et al. Inflammasome proteins as biomarkers of traumatic brain injury. PLoS One. 2018; 13: e0210128. https://doi.org/10.1371/journal.pone.0210128.

[78] Halford J, Shen S, Itamura K, Levine J, Chong AC, Czerwieniec G et al. New astroglial injury-defined biomarkers for neurotrauma assessment. J Cereb Blood Flow Metab. 2017; 37: 3278-99.

[79] Li D, Mielke MM. An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform. Neurol Ther. 2019; 8: 73-82.

[80] Gao W, Zhang Z, Lv X, Wu Q, Yan J, Mao G et al. Neurofilament light chain level in traumatic brain injury: A system review and meta-analysis. Medicine (Baltimore). 2020; 99: e22363.

[81] Mussack T, Biberthaler P, Kanz KG, Heckl U, Gruber R, Linsenmaier U, et al. Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock. 2002; 18: 395-400. https://doi.org/10.1097/00024382-200211000-00002.